Fager, Ammon M., Elizabeth Deans, and Andra H. James. “Perioperative Management of the Gynecologic Patient on Long-term Anticoagulation..” Clin Obstet Gynecol 61, no. 2 (June 2018): 278–93. https://doi.org/10.1097/GRF.0000000000000371.
Andra Hohler James, MD

I am an OB-GYN and a specialist in maternal-fetal medicine and high-risk obstetrics. My research and publications pertain mainly to the care of women with blood disorders (thrombosis and thrombophilia), bleeding disorders (including von Willebrand disease), platelet disorders (including ITP), and sickle cell disease.
Education and Training
- Associate, Obstetrics And Gynecology, Duke University, 1997 - 2000
- Resident, Obstetrics & Gynecology, North Carolina Memorial Hospital, 1993 - 1997
- M.D., University of Virginia, 1993
- M.P.H., Johns Hopkins University, 1977
Selected Grants and Awards
- Transfusion Medicine and Hematology
- Transfusion Medicine and Hematology
- A Multicenter Study on the Retrospective Safety and Efficacy of Fibrinogen Concentrate (Human) (FCH) for Routine Prophylaxis,
- Thrombosis and Hemostasis Centers Research and Prevention Network
- IPA
- Integrated Program for Persons with Hemostatic Disorders
- The Obstetrics and Gynecology Risk Group
- CDC Menorrhagia Treatment Study
- CDC PO- IUGR Study
Publications
James, Andra H. “Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option..” Clin Obstet Gynecol 61, no. 2 (June 2018): 228–34. https://doi.org/10.1097/GRF.0000000000000357.
Kulkarni, R., A. H. James, M. Norton, and A. Shapiro. “Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency..” J Thromb Haemost 16, no. 5 (May 2018): 849–57. https://doi.org/10.1111/jth.13983.
James, A. H. “Paving the way for improved management of severe immune thrombocytopenia purpura in pregnancy..” Bjog 125, no. 5 (April 2018). https://doi.org/10.1111/1471-0528.14827.
Eudy, A. M., M. Jayasundara, T. Haroun, L. Neil, A. H. James, and M. E. B. Clowse. “Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus..” Lupus 27, no. 3 (March 2018): 351–56. https://doi.org/10.1177/0961203317720525.
Srivaths, L. V., Q. C. Zhang, V. R. Byams, J. E. Dietrich, A. H. James, P. A. Kouides, R. Kulkarni, and R. Hemophilia Treatment Centers Network Investigators. “Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding..” Haemophilia 24, no. 1 (January 2018): 63–69. https://doi.org/10.1111/hae.13330.
Ahmadzia, Homa K., Jaclyn M. Phillips, Andra H. James, Madeline M. Rice, and Richard L. Amdur. “Predicting peripartum blood transfusion in women undergoing cesarean delivery: A risk prediction model..” Plos One 13, no. 12 (2018). https://doi.org/10.1371/journal.pone.0208417.
James, A. H. “Prevention and Management of Thromboembolism in Pregnancy When Heparins Are Not an Option.” Clinical Obstetrics and Gynecology 61, no. 2 (January 1, 2018): 228–34. https://doi.org/10.1097/GRF.0000000000000367.
Grotegut, Chad A., Lauren L. Lewis, Tracy A. Manuck, Terrence K. Allen, Andra H. James, Aurelien Seco, and Catherine Deneux-Tharaux. “The Oxytocin Product Correlates with Total Oxytocin Received during Labor: A Research Methods Study..” Am J Perinatol 35, no. 1 (January 2018): 78–83. https://doi.org/10.1055/s-0037-1606119.
Nuytemans, Karen, Thomas L. Ortel, Lissette Gomez, Natalia Hofmann, Natalie Alves, Nicole Dueker, Ashley Beecham, et al. “Variants in chondroitin sulfate metabolism genes in thrombotic storm..” Thromb Res 161 (January 2018): 43–51. https://doi.org/10.1016/j.thromres.2017.11.016.